Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |